OWPC
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Oct 17 closing price
Capitalization
2.03M
Intraday Buy/Sell Signals
RGEDF
Price
$29.00
Change
-$0.87 (-2.91%)
Updated
Sep 29 closing price
Capitalization
5.64B
Intraday Buy/Sell Signals
Interact to see
Advertisement

OWPC vs RGEDF

Header iconOWPC vs RGEDF Comparison
Open Charts OWPC vs RGEDFBanner chart's image
One World Products
Price$0.02
Change-$0.00 (-0.00%)
Volume$195.43K
Capitalization2.03M
Gedeon Richter
Price$29.00
Change-$0.87 (-2.91%)
Volume$600
Capitalization5.64B
OWPC vs RGEDF Comparison Chart in %
OWPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OWPC vs. RGEDF commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OWPC is a Hold and RGEDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (OWPC: $0.02 vs. RGEDF: $29.00)
Brand notoriety: OWPC and RGEDF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: OWPC: 45% vs. RGEDF: 287%
Market capitalization -- OWPC: $2.03M vs. RGEDF: $5.64B
OWPC [@Pharmaceuticals: Generic] is valued at $2.03M. RGEDF’s [@Pharmaceuticals: Generic] market capitalization is $5.64B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OWPC’s FA Score shows that 0 FA rating(s) are green whileRGEDF’s FA Score has 1 green FA rating(s).

  • OWPC’s FA Score: 0 green, 5 red.
  • RGEDF’s FA Score: 1 green, 4 red.
According to our system of comparison, RGEDF is a better buy in the long-term than OWPC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OWPC’s TA Score shows that 3 TA indicator(s) are bullish while RGEDF’s TA Score has 3 bullish TA indicator(s).

  • OWPC’s TA Score: 3 bullish, 6 bearish.
  • RGEDF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, RGEDF is a better buy in the short-term than OWPC.

Price Growth

OWPC (@Pharmaceuticals: Generic) experienced а -4.17% price change this week, while RGEDF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.79%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +51.45%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGEDF($5.64B) has a higher market cap than OWPC($2.03M). RGEDF YTD gains are higher at: 6.721 vs. OWPC (-23.651). RGEDF has higher annual earnings (EBITDA): 335B vs. OWPC (-4.79M). RGEDF has more cash in the bank: 150B vs. OWPC (81.6K). OWPC has less debt than RGEDF: OWPC (3.49M) vs RGEDF (21.6B). RGEDF has higher revenues than OWPC: RGEDF (903B) vs OWPC (2.56K).
OWPCRGEDFOWPC / RGEDF
Capitalization2.03M5.64B0%
EBITDA-4.79M335B-0%
Gain YTD-23.6516.721-352%
P/E RatioN/A8.06-
Revenue2.56K903B0%
Total Cash81.6K150B0%
Total Debt3.49M21.6B0%
FUNDAMENTALS RATINGS
OWPC vs RGEDF: Fundamental Ratings
OWPC
RGEDF
OUTLOOK RATING
1..100
5096
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
2
Undervalued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
10049
PRICE GROWTH RATING
1..100
9653
P/E GROWTH RATING
1..100
10050
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RGEDF's Valuation (2) in the null industry is somewhat better than the same rating for OWPC (37). This means that RGEDF’s stock grew somewhat faster than OWPC’s over the last 12 months.

RGEDF's Profit vs Risk Rating (69) in the null industry is in the same range as OWPC (100). This means that RGEDF’s stock grew similarly to OWPC’s over the last 12 months.

RGEDF's SMR Rating (49) in the null industry is somewhat better than the same rating for OWPC (100). This means that RGEDF’s stock grew somewhat faster than OWPC’s over the last 12 months.

RGEDF's Price Growth Rating (53) in the null industry is somewhat better than the same rating for OWPC (96). This means that RGEDF’s stock grew somewhat faster than OWPC’s over the last 12 months.

RGEDF's P/E Growth Rating (50) in the null industry is somewhat better than the same rating for OWPC (100). This means that RGEDF’s stock grew somewhat faster than OWPC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OWPCRGEDF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
42%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
29%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
47%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
39%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
26%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
29%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
12%
View a ticker or compare two or three
Interact to see
Advertisement
OWPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EDBL1.900.10
+5.56%
Edible Garden AG Incorporated
GLPG34.510.42
+1.23%
Galapagos NV
CF83.510.49
+0.59%
CF Industries Holding
ORMP2.23-0.04
-1.76%
Oramed Pharmaceuticals
MNPR80.13-2.43
-2.94%
Monopar Therapeutics Inc

OWPC and

Correlation & Price change

A.I.dvisor tells us that OWPC and OMID have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OWPC and OMID's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OWPC
1D Price
Change %
OWPC100%
+13.58%
OMID - OWPC
10%
Poorly correlated
N/A
PCLOF - OWPC
8%
Poorly correlated
N/A
RAFA - OWPC
7%
Poorly correlated
N/A
RGEDF - OWPC
4%
Poorly correlated
N/A
OILFF - OWPC
-1%
Poorly correlated
+0.11%
More

RGEDF and

Correlation & Price change

A.I.dvisor tells us that RGEDF and YCBD have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGEDF and YCBD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEDF
1D Price
Change %
RGEDF100%
N/A
YCBD - RGEDF
28%
Poorly correlated
+9.52%
OMID - RGEDF
6%
Poorly correlated
N/A
OVATF - RGEDF
6%
Poorly correlated
N/A
PCLOF - RGEDF
5%
Poorly correlated
N/A
OWPC - RGEDF
4%
Poorly correlated
+13.58%
More